Noce, A.; Albanese, M.; Marrone, G.; Di Lauro, M.; Pietroboni Zaitseva, A.; Palazzetti, D.; Guerriero, C.; Paolino, A.; Pizzenti, G.; Di Daniele, F.;
et al. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals 2021, 14, 336.
https://doi.org/10.3390/ph14040336
AMA Style
Noce A, Albanese M, Marrone G, Di Lauro M, Pietroboni Zaitseva A, Palazzetti D, Guerriero C, Paolino A, Pizzenti G, Di Daniele F,
et al. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals. 2021; 14(4):336.
https://doi.org/10.3390/ph14040336
Chicago/Turabian Style
Noce, Annalisa, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, Cristina Guerriero, Agostino Paolino, Giuseppa Pizzenti, Francesca Di Daniele,
and et al. 2021. "Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients" Pharmaceuticals 14, no. 4: 336.
https://doi.org/10.3390/ph14040336
APA Style
Noce, A., Albanese, M., Marrone, G., Di Lauro, M., Pietroboni Zaitseva, A., Palazzetti, D., Guerriero, C., Paolino, A., Pizzenti, G., Di Daniele, F., Romani, A., D’Agostini, C., Magrini, A., Mercuri, N. B., & Di Daniele, N.
(2021). Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals, 14(4), 336.
https://doi.org/10.3390/ph14040336